APREMILAST ACCORD 30 mg, film-coated tablet
Active ingredients: Apremilast
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 plaquettes unitaires PVC PVDC aluminium de (14 x 4 x 1) comprimésorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- APREMILAST ACCORD 30 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 56 plaquettes unitaires PVC PVDC aluminium de (14 x 4 x 1) comprimés
- Marketing authorisation holder
- ACCORD HEALTHCARE (ESPAGNE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66253470CIP73030401CIP133400930304013Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APRÉMILASTcomprimé | 30 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.